XOMA Royalty (STU:X0M1) Other Operating Expense : €-26.98 Mil (TTM As of Mar. 2025)

View and export this data going back to 1986. Start your Free Trial

What is XOMA Royalty Other Operating Expense?

XOMA Royalty's Other Operating Expense for the three months ended in Mar. 2025 was €-10.22 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was €-26.98 Mil.

XOMA Royalty's quarterly Other Operating Expense declined from Sep. 2024 (€-5.82 Mil) to Dec. 2024 (€-5.89 Mil) and declined from Dec. 2024 (€-5.89 Mil) to Mar. 2025 (€-10.22 Mil).

XOMA Royalty's annual Other Operating Expense increased from Dec. 2022 (€0.09 Mil) to Dec. 2023 (€0.82 Mil) but then declined from Dec. 2023 (€0.82 Mil) to Dec. 2024 (€-17.25 Mil).

XOMA Royalty Other Operating Expense Historical Data

The historical data trend for XOMA Royalty's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XOMA Royalty Other Operating Expense Chart

XOMA Royalty Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

0.09

0.82

-17.25

XOMA Royalty Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-	-5.05	-5.82	-5.89	-10.22

XOMA Royalty Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-26.98 Mil.

XOMA Royalty Other Operating Expense Related Terms

Thank you for viewing the detailed overview of XOMA Royalty's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

XOMA Royalty Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Royalty Corp (STU:X0M1) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

XOMAO.PFD:USA XOMAP.PFD:USA XOMA:USA 0M26:UK

Address

2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608

Website

https://www.xoma.com

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

XOMA Royalty Headlines

No Headlines